Home > Financial Ratios > JENBURKT PHARMACEUTICALS

JENBURKT PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for JENBURKT PHARMACEUTICALS
Please provide your vote to see the results

JENBURKT PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 6.829.005.966.836.73

What is the latest EV/Core EBITDA ratio of JENBURKT PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of JENBURKT PHARMACEUTICALS is 6.82 based on Mar2026 Standalone results.
Year EV/Core EBITDA
Mar20266.82
Mar20259.00
Mar20245.96
Mar20236.83
Mar20226.73

How is EV/Core EBITDA of JENBURKT PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2026 6.82
-24.22
Mar2025 9
51.01
Mar2024 5.96
-12.74
Mar2023 6.83
1.49
Mar2022 6.73 -

Other Financial Ratios of JENBURKT PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of JENBURKT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS ₹430.3 Cr -2.9% -6.9% -9.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,398.0 Cr -0.4% -3.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹248,664.0 Cr 0.4% 9.9% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,738.0 Cr -3.4% -4.2% 37.1% Stock Analytics
CIPLA ₹110,794.0 Cr 0.5% -3.2% -12.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,749.4 Cr 0.9% 0% -11% Stock Analytics


JENBURKT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS

-2.9%

-6.9%

-9.7%

SENSEX

-0.8%

-3.8%

-8.9%


You may also like the below Video Courses